MYELOCYTOSIS

This adverse event was reported 86 times

MYELOCYTOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LINCOMYCIN HYDROCHLORIDE 1 0.0034
1 MIGLUSTAT 3 0.0026
2 ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE 1 0.0011
3 IMIGLUCERASE 3 0.0006
4 VINBLASTINE SULFATE 1 0.0005
5 DARUNAVIR 600 MG 2 0.0003
6 DARUNAVIR 4 0.0003
7 RALTEGRAVIR 1 0.0002
8 ITRACONAZOLE 2 0.0002
9 ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE 1 0.0001
See all drugs enriched for association with MYELOCYTOSIS